{"id":8301,"date":"2025-03-28T10:08:44","date_gmt":"2025-03-28T14:08:44","guid":{"rendered":"https:\/\/www.curingheartdisease.com\/?p=8301"},"modified":"2026-08-02T12:40:58","modified_gmt":"2026-08-02T16:40:58","slug":"50%e5%b2%81%e6%8e%a5%e5%8f%97%e8%bf%87%e6%b2%bb%e7%96%97%e7%9a%84%e5%bf%83%e6%88%bf%e9%a2%a4%e5%8a%a8%e5%a4%a7%e5%b8%88%e7%ba%a7%e8%bf%90%e5%8a%a8%e5%91%98%e7%9a%84%e5%bf%83%e8%a1%80%e7%ae%a1%e9%a3%8e","status":"publish","type":"post","link":"https:\/\/www.curingheartdisease.com\/zh\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/","title":{"rendered":"\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u5fc3\u623f\u98a4\u52a8\u5408\u5e76\u5fc3\u8840\u7ba1\u98ce\u9669\u7ba1\u7406\u4e0e\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\uff0850\u5c81\u4ee5\u4e0a\uff09\u7684\u8bad\u7ec3\u8c03\u6574\uff1a\u4e13\u5bb6\u62a5\u544a"},"content":{"rendered":"

I. \u6267\u884c\u6458\u8981\uff1a\u4fee\u6539\u8bad\u7ec3\u7684\u5fc5\u8981\u6027<\/h2>\n

\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\uff08\u901a\u5e38\u5b9a\u4e49\u4e3a35\u5c81\u53ca\u4ee5\u4e0a\uff0c\u5728\u6b64\u8bed\u5883\u4e0b\u7279\u630750\u5c81\u53ca\u4ee5\u4e0a\uff09\u7684\u5fc3\u623f\u98a4\u52a8\uff08\u623f\u98a4\uff09\u7ba1\u7406\u9762\u4e34\u7740\u4e00\u9879\u4e25\u5cfb\u7684\u6311\u6218\uff0c\u8fd9\u9700\u8981\u5bf9\u8bad\u7ec3\u7406\u5ff5\u8fdb\u884c\u7ec6\u81f4\u7684\u8f6c\u53d8\u3002\u867d\u7136\u957f\u671f\u7684\u8010\u529b\u8bad\u7ec3\u53ef\u5e26\u6765\u5e7f\u6cdb\u7684\u5fc3\u8840\u7ba1\u76ca\u5904\uff0c\u4f46\u5b83\u4ece\u6839\u672c\u4e0a\u6765\u8bf4\u662f\u623f\u6027\u5fc3\u5f8b\u5931\u5e38\u7684\u4e00\u4e2a\u5242\u91cf\u4f9d\u8d56\u6027\u5371\u9669\u56e0\u7d20\u3002\u5bf9\u4e8e\u5df2\u7ecf\u63a5\u53d7\u8fc7\u623f\u98a4\u6cbb\u7597\uff08\u6d88\u878d\u6216\u836f\u7269\u6cbb\u7597\uff09\u7684\u8fd0\u52a8\u5458\u6765\u8bf4\uff0c\u7ee7\u7eed\u8fdb\u884c\u9ad8\u5f3a\u5ea6\u3001\u5927\u5242\u91cf\u7684\u8bad\u7ec3\u6781\u6709\u53ef\u80fd\u5bfc\u81f4\u5fc3\u5f8b\u5931\u5e38\u590d\u53d1\u548c\u75c5\u60c5\u8fdb\u5c55\u3002.<\/p>\n

\u7535\u751f\u7406\u5b66\u7814\u7a76\u652f\u6301\u7684\u4e3b\u8981\u7ed3\u8bba\u662f\uff0c\u88ab\u8bca\u65ad\u60a3\u6709\u623f\u98a4\u5e76\u63a5\u53d7\u4e86\u6cbb\u7597\u7684\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\uff0850\u5c81\u4ee5\u4e0a\uff09\u5e94\u7acb\u5373\u5927\u5e45\u5ea6\u964d\u4f4e\u8010\u529b\u8bad\u7ec3\u7684\u91cf\u548c\u5f3a\u5ea6\u3002.<\/strong> \u8fd9\u79cd\u51cf\u91cf\u4e0d\u4ec5\u662f\u4e3a\u4e86\u7f13\u89e3\u75c7\u72b6\uff0c\u66f4\u662f\u4f5c\u4e3a\u4e00\u79cd\u7a33\u5b9a\u5fc3\u623f\u57fa\u8d28\u5e76\u964d\u4f4e\u957f\u671f\u53d1\u75c5\u7387\u7684\u6cbb\u7597\u7b56\u7565\u3002\u5176\u76ee\u6807\u5e94\u662f\u901a\u8fc7\u6709\u89c4\u5f8b\u7684\u4e2d\u9ad8\u5f3a\u5ea6\u8fd0\u52a8\u4fdd\u6301\u9ad8\u5ea6\u7684\u5fc3\u8840\u7ba1\u5065\u5eb7\uff0c\u540c\u65f6\u79ef\u6781\u51cf\u8f7b\u4e0e\u5dc5\u5cf0\u8010\u529b\u8868\u73b0\u76f8\u5173\u7684\u7ed3\u6784\u548c\u7535\u751f\u7406\u8d1f\u8377\u3002.<\/p>\n

\u4e34\u5e8a\u7ba1\u7406\u7684\u6838\u5fc3\u652f\u67f1\uff1a<\/h3>\n
    \n
  1. \u8bad\u7ec3\u5242\u91cf\u8c03\u6574\uff1a<\/strong> \u5c06\u8bad\u7ec3\u91cf\u4ece\u957f\u671f\u7684\u3001\u9ad8\u5f3a\u5ea6\u8010\u529b\u8bad\u7ec3\uff08\u901a\u5e38\u5b9a\u4e49\u4e3a\u591a\u5e74\u6765\u6bcf\u5468\u8d85\u8fc710\u5c0f\u65f6\uff09\u4e2d\u8f6c\u79fb\u5f00 1<\/sup>).<\/li>\n
  2. \u5fc3\u5f8b\u7a33\u5b9a\u6027\u548c\u590d\u53d1\u98ce\u9669\uff1a<\/strong> \u5b9e\u65bd\u6cbb\u7597\u6027\u8fd0\u52a8\u65b9\u6848\uff0c\u4f8b\u5982\u6709\u6c27\u95f4\u6b47\u8bad\u7ec3\uff08AIT\uff09\uff0c\u5df2\u88ab\u8bc1\u660e\u53ef\u6709\u6548\u51cf\u8f7b\u623f\u98a4\u8d1f\u8377\u3002.2<\/sup><\/li>\n
  3. \u9884\u9632\u4e2d\u98ce\uff1a<\/strong> \u6839\u636e\u4e2a\u4f53\u98ce\u9669\u8bc4\u5206\uff08\u5982CHA2DS2-VASc\uff09\u9075\u5faa\u53e3\u670d\u6297\u51dd\u836f\uff08OAC\uff09\u6307\u5357\u81f3\u5173\u91cd\u8981\uff0c\u4e14\u901a\u5e38\u6bd4\u8fd0\u52a8\u76ee\u6807\u66f4\u91cd\u8981\uff0c\u56e0\u4e3a\u6210\u529f\u7684\u6d88\u878d\u5e76\u4e0d\u80fd\u666e\u904d\u4fdd\u8bc1\u514d\u53d7\u5352\u4e2d\u5a01\u80c1\u3002.4<\/sup><\/li>\n<\/ol>\n

    II. \u623f\u98a4\u590d\u53d1\u7684\u75c5\u7406\u751f\u7406\u5b66\u4e0e\u7edf\u8ba1\u5b66\u6982\u7387<\/h2>\n

    A. \u56e0\u679c\u673a\u5236\uff1a\u8010\u529b\u8bad\u7ec3\u4e0e\u5fc3\u623f\u91cd\u6784<\/h3>\n

    \u8d44\u6df1\u8fd0\u52a8\u5458\u53d1\u751f\u623f\u98a4\u7684\u98ce\u9669\u4e0e\u5176\u957f\u671f\u3001\u5927\u5bb9\u91cf\u8bad\u7ec3\u5f15\u8d77\u7684\u751f\u7406\u9002\u5e94\u5bc6\u4e0d\u53ef\u5206\uff0c\u8fd9\u901a\u5e38\u53ef\u4ee5\u7528\u8fd0\u52a8\u5242\u91cf\u4e0e\u5fc3\u8840\u7ba1\u98ce\u9669\u7684 J \u5f62\u6216 U \u5f62\u66f2\u7ebf\u6a21\u578b\u6765\u6982\u62ec\u3002.5<\/sup><\/p>\n

    \u5fc3\u810f\u7ed3\u6784\u4e0e\u7535\u751f\u7406\u57fa\u8d28<\/h4>\n

    \u8010\u529b\u8fd0\u52a8\uff08\u5982\u9a91\u884c\u3001\u8dd1\u6b65\u6216\u6e38\u6cf3\uff09\u56fa\u6709\u7684\u6162\u6027\u5bb9\u91cf\u8d1f\u8377\u4f1a\u5bfc\u81f4\u7279\u5b9a\u7684\u5fc3\u810f\u91cd\u5851\uff0c\u4ece\u800c\u5f62\u6210\u201c\u8fd0\u52a8\u5458\u5fc3\u810f\u201d\u3002.7<\/sup> \u867d\u7136\u4eba\u4eec\u5bf9\u5fc3\u5ba4\u7684\u53d8\u5316\u7ed9\u4e88\u4e86\u6781\u5927\u7684\u5173\u6ce8\uff0c\u4f46\u6b63\u662f\u5fc3\u623f\u91cd\u6784\u4f7f\u8fd0\u52a8\u5458\u6613\u60a3\u623f\u98a4\u3002\u8fd9\u79cd\u91cd\u6784\u5305\u62ec\uff1a<\/p>\n

      \n
    • \u53cc\u623f\u6269\u5927<\/strong> \u53cc\u4fa7\u5fc3\u623f\u589e\u5927\u3002.7<\/sup><\/li>\n
    • \u5fc3\u808c\u7ea4\u7ef4\u5316<\/strong> \u5fc3\u623f\u58c1\u5185\u5fae\u89c2\u7622\u75d5\uff08\u7ea4\u7ef4\u5316\uff09\u7684\u53d1\u5c55\u3002.8<\/sup><\/li>\n<\/ul>\n

      \u8fd9\u79cd\u7ea4\u7ef4\u5316\u7279\u522b\u5371\u9669\uff0c\u56e0\u4e3a\u5b83\u4f1a\u5f62\u6210\u4e00\u4e2a\u7535\u5f02\u8d28\u6027\u7684\u7ec4\u7ec7\u73af\u5883\uff0c\u4e3a\u5927\u6298\u8fd4\u7535\u56de\u8def\u7684\u5f62\u6210\u63d0\u4f9b\u9ad8\u5ea6\u6709\u5229\u7684\u57fa\u7840\u3002\u8fd9\u4e9b\u56de\u8def\u7ef4\u6301\u4e86\u623f\u98a4\u7279\u5f81\u6027\u7684\u7d0a\u4e71\u7535\u6d3b\u52a8\u3002.8<\/sup><\/p>\n

      \u81ea\u4e3b\u795e\u7ecf\u5931\u8861\u4f5c\u4e3a\u8bf1\u56e0<\/h4>\n

      \u9664\u4e86\u7ed3\u6784\u6027\u6539\u53d8\u5916\uff0c\u8010\u529b\u8fd0\u52a8\u5458\u7684\u81ea\u4e3b\u795e\u7ecf\u7cfb\u7edf\u4e5f\u4f1a\u7ecf\u5386\u663e\u8457\u7684\u6ce2\u52a8\u3002\u4ed6\u4eec\u901a\u5e38\u5728\u9759\u606f\u72b6\u6001\u4e0b\u8868\u73b0\u51fa\u589e\u5f3a\u7684\u8ff7\u8d70\u795e\u7ecf\u5f20\u529b\uff0c\u4ece\u800c\u5bfc\u81f4\u7aa6\u6027\u5fc3\u52a8\u8fc7\u7f13\u3002\u7136\u800c\uff0c\u9ad8\u5f3a\u5ea6\u6216\u7ade\u6280\u6027\u8fd0\u52a8\u4f1a\u5f15\u8d77\u5f3a\u70c8\u7684\u4ea4\u611f\u795e\u7ecf\u6fc0\u589e\u3002\u81ea\u4e3b\u795e\u7ecf\u6d3b\u6027\u7684\u8fd9\u79cd\u5267\u70c8\u6446\u52a8\u4f1a\u663e\u8457\u7f29\u77ed\u5fc3\u623f\u4e0d\u5e94\u671f\uff0c\u4f5c\u4e3a\u4e00\u4e2a\u5f3a\u6548\u7684\u5f02\u4f4d\u89e6\u53d1\u70b9\uff0c\u4ece\u800c\u5f15\u53d1\u623f\u98a4\u53d1\u4f5c\u3002.8<\/sup> \u5728\u8001\u5e74\u524d\u8fd0\u52a8\u5458\uff0850\u5c81\u4ee5\u4e0a\uff09\u4e2d\uff0c\u8fd0\u52a8\u8bf1\u5bfc\u7684\u5fc3\u810f\u91cd\u6784\u4e0e\u5e74\u9f84\u76f8\u5173\u7684\u5371\u9669\u56e0\u7d20\uff08\u4f8b\u5982\u9ad8\u8840\u538b\u6216\u80a5\u80d6\uff0c\u5373\u4f7f\u63a7\u5236\u826f\u597d\uff09\u76f8\u7ed3\u5408\uff0c\u52a0\u5267\u4e86\u8fd9\u79cd\u7535\u751f\u7406\u8106\u5f31\u6027\u3002.1<\/sup><\/p>\n

      B. \u6cbb\u7597\u540e\u590d\u53d1\u6982\u7387\u7684\u7edf\u8ba1\u6570\u636e<\/h3>\n

      \u6cbb\u7597\u540e\u4fdd\u6301\u65e0\u623f\u6027\u5fc3\u5f8b\u5931\u5e38\u72b6\u6001\u7684\u6982\u7387\u660e\u663e\u53d7\u5230\u6f5c\u5728\u75c5\u56e0\u523a\u6fc0\uff08\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\uff09\u6301\u7eed\u5b58\u5728\u7684\u6311\u6218\u3002.<\/p>\n

      \u5bfc\u7ba1\u6d88\u878d\uff08PVI\uff09\u672f\u540e\u590d\u53d1<\/h4>\n

      \u5bf9\u4e8e\u63a5\u53d7\u5bfc\u7ba1\u6d88\u878d\u672f\uff08\u7279\u522b\u662f\u80ba\u9759\u8109\u9694\u79bb\u672f\uff0cPVI\uff09\u7684\u8fd0\u52a8\u5458\u6765\u8bf4\uff0c\u590d\u53d1\u7387\u5f80\u5f80\u662f\u4e00\u4e2a\u68d8\u624b\u7684\u95ee\u9898\u3002\u89c2\u5bdf\u6027\u6570\u636e\u8868\u660e\uff0c\u8010\u529b\u8fd0\u52a8\u5458\u503e\u5411\u4e8e\u7ecf\u5386 \u623f\u6027\u5fc3\u5f8b\u5931\u5e38\u590d\u53d1\u7387\u66f4\u9ad8<\/strong> \u672f\u540e\u6bd4\u4e45\u5750\u4e0d\u52a8\u975e\u8fd0\u52a8\u5458.10<\/sup> \u81f3\u5173\u91cd\u8981\u7684\u662f\uff0c\u8fd9\u79cd\u590d\u53d1\u5f80\u5f80\u8868\u73b0\u4e3a\u800c\u4e0d\u662f\u6700\u521d\u7684\u623f\u98a4\uff0c\u800c\u662f \u4e0d\u5178\u578b\u5fc3\u623f\u6251\u52a8<\/strong>.10<\/sup> \u8fd9\u4e00\u73b0\u8c61\u8868\u660e\u75be\u75c5\u8fdb\u7a0b\u5df2\u7ecf\u8fdb\u5c55\uff0c\u539f\u6709\u7684\u80ba\u9759\u8109\u89e6\u53d1\u7076\u867d\u7136\u88ab\u6210\u529f\u9694\u79bb\uff0c\u4f46\u5728\u5fc3\u623f\u7ec4\u7ec7\u7684\u5176\u4ed6\u90e8\u4f4d\uff08\u4e0d\u4f9d\u8d56\u80ba\u9759\u8109\uff09\u5b58\u5728\u9a71\u52a8\u65b0\u53d1\u5fc3\u5f8b\u5931\u5e38\u7684\u6f5c\u5728\u7ea4\u7ef4\u5316\u57fa\u8d28\u3002.10<\/sup><\/p>\n

      \u4e00\u9879\u6bd4\u8f83PVI\u6cbb\u7597\u7ed3\u679c\u7684\u7814\u7a76\u6307\u51fa\uff0c\u4e0e\u975e\u8010\u529b\u8fd0\u52a8\u5bf9\u7167\u7ec4\u76f8\u6bd4\uff0c\u8fd0\u52a8\u5458\u57283\u5e74\u65f6\u7684\u65e0\u5fc3\u5f8b\u5931\u5e38\u751f\u5b58\u7387\u76f8\u4f3c\uff0887% \u5bf9\u6bd4 85%\uff0cp=0.88\uff09\u3002.9<\/sup> \u7136\u800c\uff0c\u53e6\u4e00\u9879\u6bd4\u8f83\u663e\u793a\uff0c3\u5e74\u540e\uff0c\u8fd0\u52a8\u5458\u7ec4\u7684\u590d\u53d1\u7387\uff08\u65e0\u623f\u98a4\u4e14\u65e0\u9700\u6297\u5fc3\u5f8b\u5931\u5e38\u6cbb\u7597\uff09\u4e3a34%\uff0c\u800c\u5bf9\u7167\u7ec4\u4e3a48%\u3002.9<\/sup> \u8fd9\u79cd\u53d8\u5f02\u7684\u542b\u4e49\u662f\uff0c\u867d\u7136\u80ba\u9759\u8109\u9694\u79bb\u672f\uff08PVI\uff09\u5bf9\u4e8e\u8fd0\u52a8\u5458\u5e38\u89c1\u7684\u8ff7\u8d70\u795e\u7ecf\u4ecb\u5bfc\u6027\u623f\u98a4\u5728\u521d\u671f\u53ef\u80fd\u6709\u6548\uff0c\u4f46\u957f\u671f\u4fdd\u6301\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u5c06\u4e0d\u53ef\u907f\u514d\u5730\u8fdb\u4e00\u6b65\u9a71\u52a8\u91cd\u6784\uff0c\u5e76\u589e\u52a0\u6700\u7ec8\u590d\u53d1\u6216\u8fdb\u5c55\u4e3a\u66f4\u590d\u6742\u5fc3\u5f8b\u5931\u5e38\uff08\u5982\u623f\u6251\uff09\u7684\u6982\u7387\u3002.10<\/sup><\/p>\n

      \u8bad\u7ec3\u8c03\u6574\u7684\u5b9a\u91cf\u6548\u76ca<\/h4>\n

      \u7ed3\u679c\u6570\u636e\u5f3a\u529b\u652f\u6301\u5bf9\u8fd0\u52a8\u91cf\u8fdb\u884c\u7ed3\u6784\u5316\u7684\u7f29\u51cf\u548c\u8c03\u6574\uff0c\u4ece\u800c\u8f6c\u5316\u4e3a\u964d\u4f4e\u590d\u53d1\u6982\u7387\u7684\u826f\u597d\u6548\u679c\u3002.<\/p>\n

        \n
      • \u76f8\u5bf9\u98ce\u9669\u964d\u4f4e<\/strong> \u7ed3\u6784\u5316\u8fd0\u52a8\u5e72\u9884\u4e0e\u603b\u4f53 \u623f\u98a4\u590d\u53d1\u98ce\u9669\u964d\u4f4e<\/strong> \u4e0e\u5bf9\u7167\u7ec4\u76f8\u6bd4\uff0c\u7528\u76f8\u5bf9\u5371\u9669\u5ea6\uff08RR\uff09\u91cf\u5316 82<\/strong> (95% CI\uff1a0.68 \u81f3 0.99\uff0cp=0.04)\u3002.3<\/sup> \u8fd9\u4e00\u51cf\u5c11\u8868\u660e\uff0c\u65e8\u5728\u7ef4\u62a4\u5065\u5eb7\u800c\u975e\u8ffd\u6c42\u6700\u9ad8\u8868\u73b0\u7684\u79d1\u5b66\u8fd0\u52a8\u5904\u65b9\uff0c\u786e\u5b9e\u5177\u6709\u6cbb\u7597\u4f5c\u7528\u3002.<\/li>\n
      • \u623f\u98a4\u8d1f\u8377\u51cf\u5c11\uff1a<\/strong> \u5177\u4f53\u800c\u8a00\uff0c\u7814\u7a76\u53d1\u73b0\uff0c\u7ed3\u6784\u5316\u6709\u6c27\u95f4\u6b47\u8bad\u7ec3\uff08AIT\uff09\u5c06\u8fd0\u52a8\u5458\u5904\u4e8e\u623f\u98a4\u72b6\u6001\u7684\u5e73\u5747\u65f6\u95f4\u51cf\u5c11\u4e86 1% \u81f3 8.1%<\/strong> \u4e0e\u5bf9\u7167\u7ec4\u76f8\u6bd4\uff0c\u5728\u5fc3\u80ba\u5065\u5eb7\uff08VO2max\uff09\u5f97\u5230\u6539\u5584\u7684\u540c\u65f6\u3002.2<\/sup><\/li>\n<\/ul>\n

        C. \u65e0\u6cd5\u63a5\u53d7\u7684\u4e2d\u98ce\u98ce\u9669<\/h3>\n

        \u5fc5\u987b\u6743\u8861\u7ee7\u7eed\u8fdb\u884c\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u7684\u51b3\u5b9a\u4e0e\u6301\u7eed\u5b58\u5728\u7684\u5352\u4e2d\u98ce\u9669\uff0c\u7279\u522b\u662f\u8003\u8651\u5230\u8be5\u8fd0\u52a8\u5458\u5df2\u5e74\u8fc750\u300250\u5c81\u4ee5\u4e0a\u7684\u4eba\u7fa4\u5176CHA2DS2-VASc\u8bc4\u5206\u5f88\u53ef\u80fd\u81f3\u5c11\u4e3a1\u5206\uff08\u56e0\u5e74\u9f84\u56e0\u7d20\uff09\uff0c\u5982\u679c\u5b58\u5728\u9ad8\u8840\u538b\u6216\u7cd6\u5c3f\u75c5\u7b49\u5176\u4ed6\u5371\u9669\u56e0\u7d20\uff0c\u5219\u53ef\u80fd\u8fbe\u52302\u5206\u6216\u66f4\u9ad8\u3002.4<\/sup><\/p>\n

        \u5352\u4e2d\u9884\u9632\u6307\u5357\u89c4\u5b9a\uff0c\u65e0\u8bba\u623f\u98a4\u6cbb\u7597\u7684\u9884\u671f\u6210\u529f\u7387\u5982\u4f55\uff0c\u90fd\u5e94\u6839\u636e CHA2DS2-VASc \u8bc4\u5206\u4f7f\u7528\u53e3\u670d\u6297\u51dd\u836f\u7269\uff08OAC\uff09\u3002.<\/p>\n

          \n
        • \u53e3\u670d\u6297\u51dd\u836f\uff08OAC\uff09\u505c\u836f\u98ce\u9669\uff1a<\/strong> \u89c2\u5bdf\u6027\u7814\u7a76\u8868\u660e\uff0c\u5bf9\u4e8eCHA2DS2-VASc\u8bc4\u5206 > 2\u7684\u60a3\u8005\uff0c\u5728\u5bfc\u7ba1\u6d88\u878d\u672f\u540e3\u4e2a\u6708\u4ee5\u4e0a\u505c\u7528\u53e3\u670d\u6297\u51dd\u836f\uff08OAC\uff09\u4f1a\u5bfc\u81f4\u4e2d\u98ce\u98ce\u9669\u5927\u5e45\u589e\u52a0\uff0c\u5176\u91cf\u5316\u6307\u6807\u4e3a \u98ce\u9669\u6bd4 (HR) \u4e3a 2.48<\/strong> (95% CI\uff0c1.11\u20135.52\uff1bP<0.05)\u3002.4<\/sup><\/li>\n
        • \u6d88\u878d\u5c40\u9650\u6027\uff1a<\/strong> \u8fc4\u4eca\u4e3a\u6b62\uff0c\u968f\u673a\u5bf9\u7167\u8bd5\u9a8c, \u672a\u8bc1\u5b9e\u80fd\u964d\u4f4e\u4e2d\u98ce\u98ce\u9669<\/strong> \u5bfc\u7ba1\u6d88\u878d\u672f\u540e.4<\/sup><\/li>\n<\/ul>\n

          \u8fd9\u4e9b\u6570\u636e\u5f3a\u8c03\u4e86\u8fd9\u6837\u4e00\u4e2a\u4e8b\u5b9e\uff1a\u6d88\u878d\u672f\u6cbb\u7597\u7684\u662f\u5fc3\u5f8b\u5931\u5e38\u7684\u75c7\u72b6\uff0c\u4f46\u53ef\u80fd\u5e76\u672a\u5b8c\u5168\u89e3\u51b3\u5bfc\u81f4\u8840\u6813\u6813\u585e\u98ce\u9669\u7684\u6f5c\u5728\u75c5\u7406\u3002\u56e0\u6b64\uff0c\u4e2d\u98ce\u7684\u6982\u7387\u4e3b\u8981\u53d6\u51b3\u4e8e CHA2DS2-VASc \u8bc4\u5206\uff0c\u800c\u4e0e\u6062\u590d\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u7684\u80fd\u529b\u65e0\u5173\u3002\u5982\u679c\u9700\u8981\u6297\u51dd\u6cbb\u7597\uff08OAC\uff09\uff0c\u5fc5\u987b\u5411\u8fd0\u52a8\u5458\u6307\u51fa\uff0c\u7531\u4e8e\u5b58\u5728\u51fa\u8840\u98ce\u9669\uff0c\u7981\u5fcc\u53c2\u4e0e\u63a5\u89e6\u6027\u6216\u9ad8\u521b\u4f24\u6027\u8fd0\u52a8\u3002.11<\/sup><\/p>\n

          III. \u5efa\u8bae\u884c\u52a8\u65b9\u6848\uff1a\u8be6\u7ec6\u57f9\u8bad\u4e0e\u4e34\u5e8a\u65b9\u6848<\/h2>\n

          \u5bf9\u4e8e\u63a5\u53d7\u8fc7\u623f\u98a4\uff08Afib\uff09\u6cbb\u7597\u7684\u8001\u5e74\u8fd0\u52a8\u5458\uff0850\u5c81\u53ca\u4ee5\u4e0a\uff09\uff0c\u5176\u5e94\u5bf9\u7b56\u7565\u5e94\u4fa7\u91cd\u4e8e\u98ce\u9669\u9632\u8303\u548c\u65e8\u5728\u589e\u5f3a\u5fc3\u810f\u6062\u590d\u529b\u7684\u7ed3\u6784\u5316\u8fd0\u52a8\u3002.<\/p>\n

          A. \u5206\u9636\u6bb5\u8bad\u7ec3\u4fee\u6539\u534f\u8bae<\/h3>\n

          \u4ece\u9ad8\u5bb9\u91cf\u8010\u529b\u8bad\u7ec3\u65b9\u6848\u5411\u6cbb\u7597\u6027\u65b9\u6848\u7684\u8f6c\u53d8\u9700\u8981\u7ed3\u6784\u5316\u7684\u5206\u9636\u6bb5\u5b9e\u65bd\u548c\u6c9f\u901a\uff0c\u7279\u522b\u662f\u5728\u8003\u8651\u5230\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u4e0e\u623f\u98a4\u8d1f\u8377\u4e4b\u95f4\u5df2\u786e\u5b9a\u7684\u5173\u8054\u65f6\u3002.5<\/sup><\/p>\n

          \u00a0<\/sup><\/p>\n\n\n\n\n\n
          \u9636\u6bb5<\/strong><\/td>\n\u6301\u7eed\u65f6\u95f4<\/strong><\/td>\n\u6d3b\u52a8\/\u76ee\u6807<\/strong><\/td>\n\u4e34\u5e8a\u57fa\u672c\u539f\u7406\u4e0e\u6307\u5bfc<\/strong><\/td>\n<\/tr>\n
          \u9636\u6bb5 1\uff1a\u5373\u523b\u672f\u540e\u6062\u590d<\/strong><\/td>\n\u6700\u521d 4\u20138 \u5468<\/td>\n\u5b8c\u5168\u505c\u6b62\u6216\u8fdb\u884c\u975e\u5e38\u8f7b\u5ea6\u7684\u3001\u975e\u7ade\u4e89\u6027\u7684\u6d3b\u52a8\uff08\u4f8b\u5982\u6563\u6b65\uff09\u3002.<\/td>\n\u6709\u52a9\u4e8e\u6d88\u878d\u6216\u5fc3\u810f\u7535\u590d\u5f8b\u540e\u7684\u5fc3\u808c\u6108\u5408\u4ee5\u53ca\u7aa6\u6027\u5fc3\u5f8b\u7684\u7a33\u5b9a\u3002.12<\/sup> \u6062\u590d\u7ed3\u6784\u5316\u4f53\u80b2\u6d3b\u52a8\u5e94\u8be5\u4ec5\u5728 \u6d88\u878d\u672f\u540e\u4e00\u4e2a\u6708<\/strong>, \uff0c\u524d\u63d0\u662f\u8be5\u7a0b\u5e8f\u5df2\u88ab\u9a8c\u8bc1\u4e3a\u6210\u529f\u3002.11<\/sup><\/td>\n<\/tr>\n
          \u9636\u6bb5 2\uff1a\u6cbb\u7597\u8d1f\u8377\u4e0e\u7ef4\u6301<\/strong><\/td>\n\u6301\u7eed\uff08\u957f\u671f\uff09<\/td>\n\u4e2d\u9ad8\u5f3a\u5ea6\u7ed3\u6784\u5316\u6709\u6c27\u8fd0\u52a8\uff0c\u4f18\u5148\u9009\u62e9\u8f83\u77ed\u3001\u8f83\u9ad8\u5f3a\u5ea6\u7684\u95f4\u6b47\u8bad\u7ec3\uff08AIT\uff09\uff0c\u800c\u975e\u957f\u65f6\u95f4\u3001\u6301\u7eed\u6027\u7684\u8bad\u7ec3\u3002.<\/td>\n\u4e3b\u8981\u957f\u671f\u76ee\u6807\u662f\u4fdd\u6301\u5fc3\u80ba\u8010\u529b\uff08\u63d0\u9ad8\u6700\u5927\u6444\u6c27\u91cf VO2max\uff09\u548c\u5fc3\u810f\u529f\u80fd\uff08\u63d0\u9ad8\u5de6\u5fc3\u5ba4\u5c04\u8840\u5206\u6570\uff0cLVEF\uff09 3<\/sup>)\uff0c\u540c\u65f6\u907f\u514d\u4e86\u8bf1\u53d1\u623f\u98a4\u7684\u6162\u6027\u5bb9\u91cf\u8d1f\u8377\u8fc7\u91cd\u3002.13<\/sup> \u5efa\u8bae\u7684\u76ee\u6807\u5927\u7ea6\u662f \u6bcf\u5468210\u5206\u949f<\/strong> \u4e2d\u7b49\u81f3\u9ad8\u5f3a\u5ea6\u6709\u6c27\u8fd0\u52a8.4<\/sup><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

          \u4f7f\u7528\u2026\u2026\u7684\u91cd\u8981\u6027 \u6709\u6c27\u95f4\u6b47\u8bad\u7ec3<\/strong> \u5728\u7b2c\u4e8c\u9636\u6bb5\u7684\u91cd\u8981\u6027\u600e\u4e48\u5f3a\u8c03\u90fd\u4e0d\u4e3a\u8fc7\uff0c\u56e0\u4e3a\u4e9a\u7ec4\u5206\u6790\u8868\u660e\u95f4\u6b47\u8bad\u7ec3\u80fd\u591f \u5728\u51cf\u5c11\u623f\u98a4\u590d\u53d1\u65b9\u9762\u5177\u6709\u66f4\u5927\u7684\u76ca\u5904<\/strong> \u4e0e\u6301\u7eed\u8bad\u7ec3\u76f8\u6bd4.3<\/sup> \u5e94\u79ef\u6781\u529d\u963b\u5168\u9762\u6062\u590d\u957f\u65f6\u95f4\u3001\u6162\u901f\u5ea6\u7684\u8010\u529b\u8bad\u7ec3\uff08>10\u5c0f\u65f6\/\u5468\uff09\uff0c\u56e0\u4e3a\u8fd9\u6709\u518d\u6b21\u8bf1\u53d1\u5bfc\u81f4\u6700\u521d\u5fc3\u5f8b\u5931\u5e38\u7684\u5fc3\u808c\u91cd\u6784\u7684\u98ce\u9669\u3002.1<\/sup><\/p>\n

          B. \u4e34\u5e8a\u7ba1\u7406\u8003\u91cf<\/h3>\n
            \n
          1. \u6297\u5fc3\u5f8b\u5931\u5e38\u836f\u7269\u4e0e\u8fd0\u52a8\u8868\u73b0\uff1a<\/strong> \u8fd0\u52a8\u5458\u901a\u5e38\u5bf9\u03b2\u53d7\u4f53\u963b\u6ede\u5242\u7b49\u836f\u7269\u4e0d\u8010\u53d7\u6216\u4e0d\u613f\u610f\u670d\u7528\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u836f\u7269\u4f1a\u4e25\u91cd\u964d\u4f4e\u4ee5\u6700\u5927\u6444\u6c27\u91cf\uff08VO2max\uff09\u8861\u91cf\u7684\u8fd0\u52a8\u5cf0\u503c\u80fd\u529b\u3002.14<\/sup> \u5bfc\u7ba1\u6d88\u878d\u901a\u5e38\u66f4\u53d7\u9752\u7750\uff0c\u56e0\u4e3a\u5b83\u63d0\u4f9b\u4e86\u6839\u6cbb\u623f\u98a4\u7684\u53ef\u80fd\u6027\uff0c\u5e76\u5141\u8bb8\u8fd0\u52a8\u5458\u5728\u65e0\u9700\u6bcf\u65e5\u670d\u7528\u9650\u5236\u8868\u73b0\u7684\u836f\u7269\u7684\u60c5\u51b5\u4e0b\u91cd\u8fd4\u8d5b\u573a\u3002.14<\/sup> \u5982\u679c\u5728\u6025\u6027\u5fc3\u810f\u590d\u5f8b\u65f6\u4f7f\u7528\u4e86\u201c\u968f\u8eab\u670d\u836f\u201d\uff08\u987f\u670d\uff09\u7684I\u7c7b\u836f\u7269\uff08\u6c1f\u5361\u5c3c\u6216\u666e\u7f57\u5e15\u916e\uff09\uff0c\u8fd0\u52a8\u5458\u5fc5\u987b\u907f\u514d\u8fdb\u884c\u5267\u70c8\u8fd0\u52a8\uff0c\u76f4\u5230 \u8be5\u836f\u7269\u5df2\u8fc7\u53bb\u4e24\u4e2a\u534a\u8870\u671f<\/strong> \uff08\u6700\u591a2\u5929\uff09\uff0c\u56e0\u4e3a\u5728\u80be\u4e0a\u817a\u7d20\u80fd\u5e94\u6fc0\u671f\u95f4\u5b58\u5728\u4fc3\u5fc3\u5f8b\u5931\u5e38\u4f5c\u7528\u7684\u98ce\u9669\u3002.11<\/sup><\/li>\n
          2. \u76d1\u6d4b\u4e0e\u8bc4\u4f30\uff1a<\/strong> \u6240\u6709\u8fd0\u52a8\u5458\u90fd\u5fc5\u987b\u5728\u4e13\u4e1a\u7684\u5fc3\u810f\u75c5\u8fd0\u52a8\u4e13\u79d1\u4e2d\u5fc3\u8fdb\u884c\u7ba1\u7406\u3002.1<\/sup> \u8fd0\u52a8\u8d1f\u8377\u8bd5\u9a8c\u5e94\u91c7\u7528\u6a21\u4eff\u8fd0\u52a8\u5458\u6240\u4ece\u4e8b\u8fd0\u52a8\u7684\u65b9\u6848\u8fdb\u884c\uff0c\u4ee5\u786e\u4fdd\u5728\u6700\u5927\u7528\u529b\u65f6\u5fc3\u5ba4\u7387\u4ecd\u4fdd\u6301\u53d7\u63a7\uff0c\u4ece\u800c\u8bc1\u5b9e\u6cbb\u7597\u6548\u679c\u3002.1<\/sup><\/li>\n
          3. \u6297\u51dd\u72b6\u6001\uff1a<\/strong> \u5fc5\u987b\u6301\u7eed\u91cd\u65b0\u8bc4\u4f30\u53e3\u670d\u6297\u51dd\u836f\uff08OAC\uff09\u7684\u72b6\u6001\u3002\u5bf9\u4e8e\u9ad8\u5371\u8fd0\u52a8\u5458\uff08CHA2DS2-VASc >2\uff09\uff0c\u5373\u4f7f\u623f\u98a4\u4f3c\u4e4e\u5df2\u5f97\u5230\u6291\u5236\uff0c\u4e5f\u5fc5\u987b\u65e0\u9650\u671f\u5730\u7ee7\u7eed\u4f7f\u7528\u53e3\u670d\u6297\u51dd\u836f\u3002.4<\/sup> \u672c\u4e34\u5e8a\u8981\u6c42\u6307\u5bfc\u8fd0\u52a8\u53c2\u4e0e\uff1b\u5bf9\u4e8e\u6b63\u5728\u63a5\u53d7\u6297\u51dd\u6cbb\u7597\u7684\u4e2a\u4f53\uff0c\u4e25\u7981\u53c2\u52a0\u8eab\u4f53\u63a5\u89e6\u6216\u5916\u4f24\u98ce\u9669\u9ad8\u7684\u8fd0\u52a8\u3002.11<\/sup><\/li>\n<\/ol>\n

            IV. \u8102\u8d28\u7ba1\u7406\u7684\u603b\u7ed3\u4e0e\u6574\u5408\uff08Stoicescu \u7b49\uff0c2025\u5e74\uff09<\/h2>\n

            \u5bf950\u5c81\u4ee5\u4e0a\u7684\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u8fdb\u884c\u6574\u4f53\u7ba1\u7406\uff0c\u4e0d\u4ec5\u9700\u8981\u89e3\u51b3\u7535\u751f\u7406\u7d0a\u4e71\uff08\u623f\u98a4\uff09\uff0c\u8fd8\u9700\u8981\u5904\u7406\u5305\u62ec\u8102\u4ee3\u8c22\u5728\u5185\u7684\u5e7f\u4e49\u5fc3\u8840\u7ba1\u98ce\u9669\u3002\u6240\u63d0\u4f9b\u7684\u8fd9\u7bc7\u7efc\u8ff0\u8bba\u6587\uff0c, \u201c\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\u529f\u80fd\u4e0e\u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff1a\u5fc3\u8840\u7ba1\u76ca\u5904\u53ca\u610f\u4e49\u201d<\/strong> 15<\/sup>, \uff0c\u4e3a\u5728\u8be5\u4eba\u7fa4\u4e2d\u7ba1\u7406\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u5fc3\u8840\u7ba1\u98ce\u9669\uff08ASCVD\uff09\u63d0\u4f9b\u4e86\u91cd\u8981\u7684\u80cc\u666f\u4fe1\u606f\u3002.<\/p>\n

            A. \u8bba\u6587\u6458\u8981\uff1aHDL\u529f\u80fd\u4e0e\u5c0f\u800c\u5bc6LDL<\/h3>\n

            Stoicescu\u3001Vacarescu\u548cCozma\u7684\u7efc\u8ff0\u5f3a\u8c03\u4e86\u8102\u8d28\u5b66\u9886\u57df\u7684\u4e00\u4e2a\u91cd\u5927\u8303\u5f0f\u8f6c\u53d8\uff1a\u5173\u6ce8\u70b9\u5df2\u4ece\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\u80c6\u56fa\u9187\uff08HDL-C\uff09\u6d53\u5ea6\u8f6c\u79fb\u5230\u5176\u529f\u80fd\u5bb9\u91cf\u4ee5\u53ca\u79ef\u6781\u51cf\u5c11\u81f4\u52a8\u8109\u7ca5\u6837\u786c\u5316\u9897\u7c92\u4e0a\u3002.17<\/sup><\/p>\n

              \n
            1. HDL\u7126\u70b9\uff1a\u91cd\u8d28\u4e0d\u91cd\u91cf<\/strong> \u867d\u7136\u4f20\u7edf\u4e0a\u8ba4\u4e3a\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\uff08HDL\uff09\u5177\u6709\u5fc3\u810f\u4fdd\u62a4\u4f5c\u7528\uff0c\u4f46\u901a\u8fc7\u70df\u9178\uff08AIM-HIGH\u3001HPS2-THRIVE \u8bd5\u9a8c\uff09\u6216 CETP \u6291\u5236\u5242\uff08ILLUMINATE\u3001ACCELERATE \u8bd5\u9a8c\uff09\u7b49\u836f\u7269\u63d0\u9ad8 HDL-C \u6d53\u5ea6\uff0c\u5e76\u672a\u6301\u7eed\u964d\u4f4e\u5fc3\u8840\u7ba1\u4e8b\u4ef6\u7684\u53d1\u751f\u7387\u3002.16<\/sup> \u5176\u9884\u6d4b\u548c\u4fdd\u62a4\u4ef7\u503c\u53cd\u800c\u5728\u4e8e HDL \u529f\u80fd<\/strong>, \uff0c\u5c24\u5176\u662f\u5b83\u7684 \u80c6\u56fa\u9187\u5916\u6d41\u80fd\u529b<\/strong>, \uff0c\u8fd9\u4ee3\u8868\u4e86\u5176\u6e05\u9664\u52a8\u8109\u6591\u5757\u4e2d\u5de8\u566c\u7ec6\u80de\u5185\u80c6\u56fa\u9187\u7684\u80fd\u529b\u3002.16<\/sup><\/li>\n
            2. sdLDL\uff1a\u4e3b\u8981\u7684\u81f4\u52a8\u8109\u7ca5\u6837\u786c\u5316\u9776\u70b9\uff1a<\/strong> \u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff08sdLDL\uff09\u9897\u7c92\u88ab\u8ba4\u4e3a\u5177\u6709\u6781\u9ad8\u7684\u81f4\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u3002.16<\/sup> \u5b83\u4eec\u7684\u7269\u7406\u7279\u6027\u2014\u2014\u4f53\u578b\u5c0f\u3001\u5bc6\u5ea6\u9ad8\u4ee5\u53ca\u6297\u6c27\u5316\u5242\u542b\u91cf\u4f4e\u2014\u2014\u4f7f\u5176\u80fd\u591f\u9ad8\u6548\u5730\u7a7f\u900f\u52a8\u8109\u5185\u819c\u5e76\u53d1\u751f\u6c27\u5316\u4fee\u9970\u3002.15<\/sup> \u6b64\u5916\uff0c\u5b83\u4eec\u5ef6\u957f\u7684\u8840\u6d46\u534a\u8870\u671f\uff08\u957f\u8fbe74\u5c0f\u65f6\uff09\u589e\u52a0\u4e86\u5176\u5728\u5185\u76ae\u73af\u5883\u4e2d\u7684\u66b4\u9732\u65f6\u95f4\u3002.15<\/sup> \u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\u80c6\u56fa\u9187\uff08sdLDL\uff09\u6d53\u5ea6\u5347\u9ad8\u4e0e\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u5fc3\u8840\u7ba1\u75be\u75c5\uff08ASCVD\uff09\u4e8b\u4ef6\u98ce\u9669\u589e\u52a0\u5bc6\u5207\u76f8\u5173\uff08\u8c03\u6574\u540e\u5371\u9669\u6bd4\uff1a1.21 \u81f3 1.52\uff09\u3002.16<\/sup><\/li>\n
            3. \u6cbb\u7597\u5171\u8bc6\uff1a<\/strong> \u73b0\u884c\u6307\u5357\u4f18\u5148\u8003\u8651\u964d\u4f4e\u81f4\u52a8\u8109\u7ca5\u6837\u786c\u5316\u8102\u86cb\u767d\u7684\u6574\u4f53\u8d1f\u62c5\uff0c\u8fd9\u5728\u5b9e\u9645\u64cd\u4f5c\u4e2d\u901a\u8fc7\u975e\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\u80c6\u56fa\u9187\uff08non-HDL-C\uff09\u6216\u8f7d\u8102\u86cb\u767d B\uff08ApoB\uff09\u6765\u8861\u91cf\uff0c\u4ece\u800c\u6709\u6548\u5730\u9488\u5bf9\u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff08sdLDL\uff09\u548c\u6b8b\u7c92\u9897\u7c92\u3002\u4ed6\u6c40\u7c7b\u836f\u7269\u548c PCSK9 \u6291\u5236\u5242\u4ecd\u7136\u662f\u6cbb\u7597\u7684\u57fa\u7840\uff0c\u53ef\u964d\u4f4e LDL-C \u548c ApoB\u3002.16<\/sup><\/li>\n<\/ol>\n

              B. \u4e09\u9636\u6574\u5408\uff1a\u53cc\u91cd\u98ce\u9669\u7ba1\u7406\u7b56\u7565<\/h3>\n

              \u5728\u8001\u9f84\u8fd0\u52a8\u5458\u4e2d\uff0c\u9a71\u52a8\u623f\u98a4\u98ce\u9669\u7684\u751f\u7406\u673a\u5236\uff08\u91cd\u6784\/\u7ea4\u7ef4\u5316\uff09\u4e0e\u9a71\u52a8\u52a8\u8109\u7ca5\u6837\u786c\u5316\u98ce\u9669\u7684\u673a\u5236\uff08\u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\u805a\u79ef\/\u708e\u75c7\uff09\u5f80\u5f80\u76f8\u4e92\u91cd\u53e0\u3002\u5fc5\u987b\u91c7\u53d6\u7efc\u5408\u5168\u9762\u7684\u65b9\u6cd5\u3002.<\/p>\n

              \u901a\u8fc7\u9002\u5ea6\u8fd0\u52a8\u63a7\u5236\u623f\u98a4\u590d\u53d1\u7684\u5fc5\u8981\u6027\uff0c\u53cd\u8fc7\u6765\u652f\u6301\u4e86\u901a\u8fc7\u751f\u6d3b\u65b9\u5f0f\u4f18\u5316\u8840\u8102\u8c31\uff1a<\/p>\n

                \n
              1. \u751f\u6d3b\u65b9\u5f0f\u534f\u540c\u4f5c\u7528<\/strong> \u6709\u89c4\u5f8b\u7684\u4f53\u80b2\u6d3b\u52a8\uff08\u4e2d\u9ad8\u5f3a\u5ea6\u8fd0\u52a8\uff09\u548c\u9002\u5f53\u7684\u996e\u98df\u8c03\u6574\uff08\u4f8b\u5982\u5730\u4e2d\u6d77\u996e\u98df\uff0c\u5bcc\u542b\u6a44\u6984\u6cb9\u7b49\u4e0d\u9971\u548c\u8102\u80aa\uff09 16<\/sup>, \uff0c\u4e14\u5bcc\u542b\u672a\u7cbe\u5236\u78b3\u6c34\u5316\u5408\u7269\uff09\u53ef\u540c\u65f6\u89e3\u51b3\u8fd9\u4e24\u79cd\u5fc3\u810f\u98ce\u9669\u3002\u8fd9\u4e9b\u6539\u53d8\u6539\u5584\u4e86\u6574\u4f53\u5fc3\u810f\u4ee3\u8c22\u8c31\uff0c\u589e\u5f3a\u4e86HDL\u7684\u529f\u80fd\u5bb9\u91cf\uff08\u63d0\u9ad8CEC\u548c\u6297\u6c27\u5316\u6f5c\u529b\uff09\uff0c\u5e76\u964d\u4f4e\u4e86\u8840\u6d46\u7518\u6cb9\u4e09\u916f\u6c34\u5e73\uff0c\u4ece\u800c\u51cf\u5c11\u4e86\u809d\u810f\u5bf9sdLDL\u7684\u4ea7\u751f\u3002.16<\/sup><\/li>\n
              2. \u9776\u5411\u6b8b\u4f59\u98ce\u9669\u7f13\u89e3\uff08Omega-3\uff09\uff1a<\/strong> \u9274\u4e8esdLDL\u548c\u6b8b\u4f59\u9897\u7c92\u4e0eASCVD\u7684\u9ad8\u98ce\u9669\u76f8\u5173\uff0c\u5982\u679c\u5c3d\u7ba1\u8fdb\u884c\u4e86\u6700\u4f73\u4ed6\u6c40\u7c7b\u836f\u7269\u6cbb\u7597\u548c\u751f\u6d3b\u65b9\u5f0f\u8c03\u6574\uff0c\u9ad8\u7518\u6cb9\u4e09\u916f\u8840\u75c7\uff08\u4f8b\u5982\uff1e150 mg\/dL\uff09\u4ecd\u6301\u7eed\u5b58\u5728\uff0c\u5219\u53ef\u80fd\u9700\u8981\u8fdb\u884c\u836f\u7269\u5e72\u9884\u3002 \u5728REDUCE-IT\u8bd5\u9a8c\u4e2d\uff0c\u9ad8\u5242\u91cf\u836f\u7528\u7ea7\u4e8c\u5341\u78b3\u4e94\u70ef\u9178\uff08EPA\uff09\u663e\u793a\u51fa\u53ef\u5c06\u4e3b\u8981\u5fc3\u8840\u7ba1\u4e8b\u4ef6\u7684\u76f8\u5bf9\u98ce\u9669\u964d\u4f4e25%\u3002.16<\/sup> \u8fd9\u662f\u4e00\u79cd\u9488\u5bf9\u7531sdLDL\u5f15\u53d1\u7684\u6b8b\u4f59\u98ce\u9669\u7684\u9776\u5411\u6cbb\u7597\u3002.<\/li>\n
              3. EPA \u4f7f\u7528\u4e2d\u7684\u5173\u952e\u7ec6\u5fae\u5dee\u522b\uff1a<\/strong> \u5bf9\u4e8e\u5df2\u88ab\u8bca\u65ad\u4e3a\u623f\u98a4\u7684\u60a3\u8005\uff0c\u4e00\u4e2a\u81f3\u5173\u91cd\u8981\u7684\u8003\u91cf\u662f\u4f17\u6240\u5468\u77e5\u7684\u4e0e\u9ad8\u5242\u91cf\u6b27\u7c73\u4f3d-3\u8102\u80aa\u9178\u76f8\u5173\u7684\u5fc3\u623f\u98a4\u52a8\u53d1\u75c5\u7387\u589e\u52a0\u7684\u53ef\u80fd\u6027\u3002.16<\/sup> \u51b3\u5b9a\u4f7f\u7528\u5927\u5242\u91cf EPA \u9700\u8981\u4e0e\u7535\u751f\u7406\u5b66\u5bb6\u8fdb\u884c\u4ed4\u7ec6\u534f\u5546\uff0c\u4ee5\u6743\u8861 ASCVD \u98ce\u9669\u964d\u4f4e\u7684\u786e\u5b9a\u76ca\u5904\u4e0e\u52a0\u91cd\u6f5c\u5728\u5fc3\u5f8b\u5931\u5e38\u7684\u53ef\u80fd\u6027\u3002.<\/li>\n<\/ol>\n

                \u4e94\u3001\u7ed3\u8bba\u4e0e\u5efa\u8bae<\/h2>\n

                \u5bf9\u4e8e\u6210\u529f\u63a5\u53d7\u623f\u98a4\u6cbb\u7597\u7684 50 \u5c81\u53ca\u4ee5\u4e0a\u8001\u8fd0\u52a8\u5458\uff0c\u4e34\u5e8a\u6570\u636e\u5f3a\u70c8\u8868\u660e\uff0c\u7ee7\u7eed\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u4ee3\u8868\u7740\u5bf9\u957f\u671f\u5fc3\u810f\u7a33\u5b9a\u6027\u7684\u5347\u9ad8\u4e14\u533b\u5b66\u4e0a\u4e0d\u53ef\u63a5\u53d7\u7684\u98ce\u9669\u3002\u51cf\u7f13\u5e76\u91cd\u7ec4\u9ad8\u5f3a\u5ea6\u8bad\u7ec3\u662f\u6cbb\u7597\u7684\u5f3a\u5236\u6027\u7ec4\u6210\u90e8\u5206\uff0c\u800c\u975e\u4e3b\u89c2\u7684\u751f\u6d3b\u65b9\u5f0f\u9009\u62e9\u3002.<\/p>\n

                \u7edf\u8ba1\u6982\u7387\u538b\u5012\u6027\u5730\u652f\u6301\u8fdb\u884c\u5e72\u9884\uff1a<\/p>\n

                  \n
                • \u623f\u98a4\u590d\u53d1\u548c\u8fdb\u5c55\uff08\u4f8b\u5982\u53d1\u5c55\u4e3a\u975e\u5178\u578b\u623f\u6251\uff09\u7684\u6982\u7387\u4f9d\u7136 \u9ad8<\/strong> \u5982\u679c\u8be5\u8fd0\u52a8\u5458\u7ef4\u6301\u957f\u671f\u7684\u3001\u5927\u8fd0\u52a8\u91cf\u7684\u8010\u529b\u8bad\u7ec3\uff0c\u56e0\u4e3a\u8fd9\u4f1a\u4f7f\u6f5c\u5728\u7684\u5fc3\u623f\u7ea4\u7ef4\u5316\u6301\u7eed\u5b58\u5728\u3002.8<\/sup><\/li>\n
                • \u5b9e\u65bd\u7ed3\u6784\u5316\u7684\u6cbb\u7597\u6027\u8fd0\u52a8\u5242\u91cf\uff08\u6bcf\u5468\u7ea6210\u5206\u949f\u7684\u4e2d\u9ad8\u5f3a\u5ea6\u6d3b\u52a8\uff0c\u504f\u5411\u95f4\u6b47\u8bad\u7ec3\uff09\u53ef\u79ef\u6781\u964d\u4f4e\u623f\u98a4\u590d\u53d1\u7684\u6982\u7387\uff08RR 0.82\uff09\u3002.3<\/sup><\/li>\n
                • \u4e2d\u98ce\u4e8b\u4ef6\u7684\u53d1\u751f\u6982\u7387\u663e\u8457\u589e\u52a0\uff08HR > 2.5<\/strong>) \u5982\u679c\u9ad8\u98ce\u9669\u8fd0\u52a8\u5458\uff08CHA2DS2-VASc >2\uff09\u8fc7\u65e9\u505c\u7528\u53e3\u670d\u6297\u51dd\u836f\uff08OAC\uff09\uff0c\u8fd9\u5f3a\u8c03\u4e86\u8282\u5f8b\u7a33\u5b9a\u6027\u5e76\u4e0d\u80fd\u6d88\u9664\u8840\u6813\u6813\u585e\u98ce\u9669\u3002.4<\/sup><\/li>\n<\/ul>\n

                  \u5efa\u8bae\u91c7\u53d6\u7684\u884c\u52a8\u65b9\u6848<\/h3>\n
                    \n
                  1. \u5f3a\u5236\u57f9\u8bad\u73ed\u6b21\uff1a<\/strong> \u8be5\u8fd0\u52a8\u5458\u5fc5\u987b\u5c06\u8bad\u7ec3\u76ee\u6807\u4ece\u8ffd\u6c42\u6781\u81f4\u8010\u529b\u8868\u73b0\u8f6c\u53d8\u4e3a\u7ef4\u62a4\u5fc3\u8840\u7ba1\u5065\u5eb7\u3002\u8fd9\u5305\u62ec\u5c06\u8bad\u7ec3\u91cf\u964d\u81f3\u957f\u671f\u9ad8\u5242\u91cf\u9608\u503c\u4ee5\u4e0b\uff08\u5373\u6bcf\u5468\u9ad8\u5f3a\u5ea6\u6d3b\u52a8\u5c11\u4e8e10\u5c0f\u65f6\uff09\uff0c\u5e76\u4ee5\u7ed3\u6784\u5316\u7684\u95f4\u6b47\u8bad\u7ec3\u4e3a\u91cd\u70b9\uff0c\u4ee5\u7ef4\u6301\u4f53\u80fd\u5e76\u51cf\u8f7b\u623f\u98a4\u8d1f\u62c5\u3002.<\/li>\n
                  2. \u5352\u4e2d\u9884\u9632\u4f9d\u4ece\u6027\uff1a<\/strong> OAC\u72b6\u6001\u5fc5\u987b\u4e25\u683c\u9075\u5faa\u57fa\u4e8eCHA2DS2-VASc\u8bc4\u5206\u7684\u6307\u5357\u5efa\u8bae\u3002\u5bf9\u4e8e\u5927\u591a\u657050\u5c81\u4ee5\u4e0a\u4e14\u60a3\u6709\u5df2\u6cbb\u7597\u623f\u98a4\u7684\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u800c\u8a00\uff0c\u901a\u5e38\u9700\u8981\u7ee7\u7eed\u8fdb\u884cOAC\u6cbb\u7597\uff0c\u8fd9\u5c31\u5fc5\u987b\u907f\u514d\u63a5\u89e6\u6027\u8fd0\u52a8\u6216\u9ad8\u521b\u4f24\u6027\u8fd0\u52a8\u3002.<\/li>\n
                  3. \u5168\u9762\u98ce\u9669\u7ba1\u7406<\/strong> \u5c06\u623f\u98a4\u7684\u7ba1\u7406\u4e0e\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u5fc3\u8840\u7ba1\u75be\u75c5\uff08ASCVD\uff09\u7684\u63a7\u5236\u7ed3\u5408\u8d77\u6765\u3002\u4f18\u5148\u91c7\u53d6\u80fd\u591f\u589e\u5f3a\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\uff08HDL\uff09\u529f\u80fd\u5e76\u51cf\u5c11\u9ad8\u81f4\u52a8\u8109\u7ca5\u6837\u786c\u5316\u6027\u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff08sdLDL\uff09\u9897\u7c92\u7684\u751f\u6d3b\u65b9\u5f0f\u56e0\u7d20\uff08\u81b3\u98df\u8102\u80aa\u7ec4\u6210\u3001\u78b3\u6c34\u5316\u5408\u7269\u9650\u5236\uff09\u3002.16<\/sup> \u4efb\u4f55\u8f85\u52a9\u6cbb\u7597\uff08\u4f8b\u5982\u7528\u4e8e\u9ad8\u7518\u6cb9\u4e09\u916f\u8840\u75c7\u7684\u5927\u5242\u91cf EPA\uff09\u90fd\u9700\u8981\u4ed4\u7ec6\u6743\u8861\uff0c\u56e0\u4e3a\u8fd9\u53ef\u80fd\u4f1a\u5bf9\u623f\u98a4\u8d1f\u8377\u4ea7\u751f\u6f5c\u5728\u7684\u76f8\u4e92\u4f5c\u7528\u3002.<\/li>\n
                  4. \u4e13\u5bb6\u76d1\u63a7<\/strong> \u8fd0\u52a8\u5458\u91cd\u8fd4\u8d5b\u573a\u548c\u8bad\u7ec3\u5f3a\u5ea6\u7684\u786e\u5b9a\uff0c\u5fc5\u987b\u5728\u4e13\u6ce8\u4e8e\u8fd0\u52a8\u7535\u751f\u7406\u5b66\u7684\u5fc3\u810f\u75c5\u5b66\u56e2\u961f\u6307\u5bfc\u4e0b\u8fdb\u884c\uff0c\u901a\u8fc7\u8fde\u7eed\u76d1\u6d4b\u548c\u8fd0\u52a8\u8d1f\u8377\u8bd5\u9a8c\uff0c\u4ee5\u786e\u8ba4\u5728\u8fd0\u52a8\u8fc7\u7a0b\u4e2d\u7684\u5fc3\u5f8b\u548c\u5fc3\u7387\u63a7\u5236\u60c5\u51b5\u3002.1<\/sup><\/li>\n<\/ol>\n

                    \"\"\"\"\"\"<\/h3>\n

                    \u53c2\u8003\u6587\u732e<\/h3>\n
                      \n
                    1. Mont L, Elosua R, Brugada J. \u8010\u529b\u8fd0\u52a8\u5b9e\u8df5\u4f5c\u4e3a\u623f\u98a4\u548c\u623f\u6251\u7684\u5371\u9669\u56e0\u7d20\u3002.\u00a0\u6b27\u6d32\u8d77\u640f\u4e0e\u5fc3\u7535\u56fe\u5b66\u6742\u5fd7<\/i>. 2009;11(1):11-17. doi:10.1093\/europace\/eun289<\/li>\n
                    2. Malmo V, Nes BM, Amundsen BH, \u7b49\u3002\u6709\u6c27\u95f4\u6b47\u8bad\u7ec3\u53ef\u5728\u77ed\u671f\u5185\u51cf\u8f7b\u5fc3\u623f\u98a4\u52a8\u7684\u8d1f\u62c5\uff1a\u4e00\u9879\u968f\u673a\u8bd5\u9a8c\u3002.\u00a0\u5faa\u73af<\/i>. 2016;133(5):466-473. doi:10.1161\/CIRCULATIONAHA.115.018220<\/li>\n
                    3. \u6df1\u7530 E, \u54c8\u5c14\u8fbe\u5c3c R,\u7a46\u8482 N,\u666e\u62c9\u7eb3\u74e6 F,\u9c81\u65af\u5357\u5854 F,\u91cc\u8428\u5c14 A. \u4f53\u80b2\u953b\u70bc\u5e72\u9884\u6539\u5584\u975e\u6c38\u4e45\u6027\u5fc3\u623f\u98a4\u52a8\u60a3\u8005\u7684\u5fc3\u810f\u529f\u80fd\u5e76\u51cf\u5c11\u590d\u53d1\uff1a\u7cfb\u7edf\u8bc4\u4ef7\u4e0eMeta\u5206\u6790\u3002.\u00a0\u6c99\u7279\u5fc3\u810f\u75c5\u5b66\u534f\u4f1a\u6742\u5fd7<\/i>. 2025;37(4):1459. Published 2025 Oct 10. doi:10.37616\/2212-5043.1459<\/li>\n
                    4. Noseworthy PA, Yao X, Deshmukh AJ, et al. \u623f\u98a4\u5bfc\u7ba1\u6d88\u878d\u672f\u540e\u6297\u51dd\u836f\u7269\u7684\u4f7f\u7528\u6a21\u5f0f\u53ca\u5fc3\u6e90\u6027\u6813\u585e\u98ce\u9669\u3002.\u00a0\u7f8e\u56fd\u5fc3\u810f\u534f\u4f1a\u6742\u5fd7<\/i>. 2015;4(11):e002597. Published 2015 Nov 5. doi:10.1161\/JAHA.115.002597<\/li>\n
                    5. \u74dc\u65bd E\uff0c\u8499\u7279 L\u3002\u8fd0\u52a8\u8bf1\u53d1\u6027\u5fc3\u5f8b\u5931\u5e38\u7684\u8bca\u65ad\u3001\u75c5\u7406\u751f\u7406\u5b66\u53ca\u7ba1\u7406\u3002.\u00a0\u81ea\u7136\u7efc\u8ff0\uff1a\u5fc3\u810f\u75c5\u5b66\u6742\u5fd7<\/i>. 2017;14(2):88-101. doi:10.1038\/nrcardio.2016.173<\/li>\n
                    6. Pelliccia A, Maron BJ, Di Paolo FM, et al. \u7ade\u6280\u8fd0\u52a8\u5458\u5de6\u5fc3\u623f\u91cd\u6784\u7684\u60a3\u75c5\u7387\u53ca\u4e34\u5e8a\u610f\u4e49\u3002.\u00a0\u7f8e\u56fd\u5fc3\u810f\u75c5\u5b66\u4f1a\u6742\u5fd7<\/i>. 2005;46(4):690-696. doi:10.1016\/j.jacc.2005.04.052<\/li>\n
                    7. Benito B, Gay-Jordi G, Serrano-Mollar A, et al. \u957f\u671f\u5927\u5f3a\u5ea6\u8fd0\u52a8\u8bad\u7ec3\u5927\u9f20\u6a21\u578b\u4e2d\u7684\u5fc3\u810f\u81f4\u5fc3\u5f8b\u5931\u5e38\u6027\u91cd\u6784\u3002.\u00a0\u5faa\u73af<\/i>. 2011;123(1):13-22. doi:10.1161\/CIRCULATIONAHA.110.938282<\/li>\n
                    8. \u5361\u7279\u91cc\u8328is G\uff0c\u5361\u5c14\u91d1\u65af H\u3002\u623f\u98a4\u5bfc\u7ba1\u6d88\u878d\u2014\u2014\u6280\u672f\u4e0e\u5de5\u827a\u3002.\u00a0\u5fc3\u5f8b\u4e0e\u7535\u751f\u7406\u5b66\u8bc4\u8bba<\/i>. 2012;1(1):29-33. doi:10.15420\/aer.2012.1.29<\/li>\n
                    9. Calvo N, Mont L, Tamborero D, et al. \u73af\u80ba\u9759\u8109\u6d88\u878d\u672f\u6cbb\u7597\u8010\u529b\u8fd0\u52a8\u5458\u5fc3\u623f\u98a4\u52a8\u7684\u7597\u6548\u3002.\u00a0\u6b27\u6d32\u8d77\u640f\u4e0e\u5fc3\u7535\u56fe\u5b66\u6742\u5fd7<\/i>. 2010;12(1):30-36. doi:10.1093\/europace\/eup320<\/li>\n
                    10. \u6d77\u5fb7\u5e03\u8d6b\u5c14 H\uff0c\u6f58\u80e1\u4f0a\u5c91-\u53e4\u5fb7\u79d1\u666e N\uff0c\u79d1\u62c9\u591a D \u7b49\u3002 \u5177\u6709\u5fc3\u5f8b\u5931\u5e38\u53ca\u6f5c\u5728\u81f4\u5fc3\u5f8b\u5931\u5e38\u75be\u75c5\u60a3\u8005\u53c2\u52a0\u4f11\u95f2\u4f53\u80b2\u6d3b\u52a8\u548c\u7ade\u6280\u4f53\u80b2\u7684\u5efa\u8bae \u7b2c\u4e00\u90e8\u5206\uff1a\u5ba4\u4e0a\u6027\u5fc3\u5f8b\u5931\u5e38\u548c\u5fc3\u810f\u8d77\u640f\u5668\u3002.\u00a0\u6b27\u6d32\u5fc3\u8840\u7ba1\u9884\u9632\u4e0e\u5eb7\u590d\u6742\u5fd7<\/i>. 2006;13(4):475-484. doi:10.1097\/01.hjr.0000216543.54066.72<\/li>\n
                    11. \u4f69\u5229\u6070 A\u3001\u590f\u5c14\u9a6c S\u3001\u52a0\u8482 S \u7b49\u4eba\u30022020 \u5e74\u6b27\u6d32\u5fc3\u810f\u75c5\u5b66\u4f1a\uff08ESC\uff09\u5173\u4e8e\u5fc3\u8840\u7ba1\u75be\u75c5\u60a3\u8005\u4f53\u80b2\u5fc3\u810f\u75c5\u5b66\u548c\u8fd0\u52a8\u6307\u5357\u3002.\u00a0\u6b27\u6d32\u5fc3\u810f\u75c5\u5b66\u6742\u5fd7<\/i>. 2021;42(1):17-96. doi:10.1093\/eurheartj\/ehaa605<\/li>\n
                    12. Elliott AD, Mahajan R, Lau DH, Sanders P. \u8010\u529b\u8fd0\u52a8\u5458\u7684\u5fc3\u623f\u98a4\u52a8\uff1a\u4ece\u673a\u5236\u5230\u7ba1\u7406\u3002.\u00a0\u5fc3\u810f\u75c5\u5b66\u4e34\u5e8a\u6742\u5fd7<\/i>. 2016;34(4):567-578. doi:10.1016\/j.ccl.2016.06.006<\/li>\n
                    13. Menezes AR, Lavie CJ, De Schutter A, et al. \u751f\u6d3b\u65b9\u5f0f\u6539\u53d8\u5728\u623f\u98a4\u9884\u9632\u548c\u6cbb\u7597\u4e2d\u7684\u4f5c\u7528\u3002.\u00a0\u5fc3\u8840\u7ba1\u75be\u75c5\u8fdb\u5c55<\/i>. 2015;58(2):117-125. doi:10.1016\/j.pcad.2015.07.001<\/li>\n
                    14. Lobo HM, Naves \u00cdG, Mar\u00e7al SB, Canzi CC, Rodrigues ABS, Menezes AS Jr. \u8010\u529b\u8bad\u7ec3\u8fd0\u52a8\u5458\u7684\u5fc3\u623f\u98a4\u52a8\uff1a\u8303\u56f4\u7efc\u8ff0\u3002.\u00a0\u5fc3\u8840\u7ba1\u533b\u5b66\u8bc4\u8bba<\/i>. 2023;24(6):155. Published 2023 May 26. doi:10.31083\/j.rcm2406155<\/li>\n
                    15. Stoicescu C, Vacarescu C, Cozma D. HDL \u529f\u80fd\u4e0e\u5c0f\u800c\u5bc6\u4f4e\u5bc6\u5ea6\u8102\u86cb\u767d\uff1a\u5fc3\u8840\u7ba1\u83b7\u76ca\u4e0e\u610f\u4e49\u3002.\u00a0\u4e34\u5e8a\u533b\u5b66\u6742\u5fd7<\/i>. 2025;14(14):4945. Published 2025 Jul 12. doi:10.3390\/jcm14144945<\/li>\n
                    16. \u5df4\u7279 DL,\u65af\u7279\u683c PG,\u7c73\u52d2 M,\u7b49. \u4e8c\u5341\u78b3\u4e94\u70ef\u9178\u4e59\u916f\u7528\u4e8e\u9ad8\u7518\u6cb9\u4e09\u916f\u8840\u75c7\u7684\u5fc3\u8840\u7ba1\u98ce\u9669\u964d\u4f4e.\u00a0\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7<\/i>. 2019;380(1):11-22. doi:10.1056\/NEJMoa1812792<\/li>\n
                    17. \u00a0<\/span>\u7f57\u54c8\u7279\u5409 A\uff0c\u51ef\u62c9 A\uff0c\u8d1d\u91cc JD\uff0c\u7b49\u3002\u9ad8\u5bc6\u5ea6\u8102\u86cb\u767d\u80c6\u56fa\u9187\u5916\u6392\u80fd\u529b\u4e0e\u65b0\u53d1\u5fc3\u8840\u7ba1\u4e8b\u4ef6\u3002.\u00a0\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7<\/i>. 2014;371(25):2383-2393. doi:10.1056\/NEJMoa1409065<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"

                      \u8ba4\u8bc6\u4e00\u4e0b\u201c\u8d44\u6df1\u8fd0\u52a8\u5458\u201d\u3002\u8fd9\u662f\u4e00\u4f4d\u5e74\u8fc7\u4e94\u5341\u3001\u611f\u89c9\u81ea\u5df1\u6b63\u5904\u4e8e\u4eba\u751f\u9ec4\u91d1\u65f6\u671f\u7684\u4eba\u3002\u4ed6\u4eec\u53c2\u52a0\u957f\u8dd1\uff0c\u9a91\u884c\u6570\u767e\u82f1\u91cc\uff0c\u5e76\u5728\u6cf3\u6c60\u91cc\u6ce1\u4e0a\u51e0\u4e2a\u5c0f\u65f6\u3002\u5728\u5916\u4eba\u770b\u6765\uff0c\u4ed6\u4eec\u5c31\u662f\u5065\u5eb7\u7684\u5316\u8eab\u3002\u4ed6\u4eec\u62e5\u6709\u7f13\u6162\u800c\u5e73\u7a33\u7684\u9759\u606f\u8109\u640f\u548c\u5145\u6c9b\u7684\u7cbe\u529b\u3002.<\/p>","protected":false},"author":16,"featured_media":8302,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[228,218,225,226],"tags":[],"class_list":["post-8301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-athletes-and-heart-risk","category-exercise-athletes-and-aging","category-risk-genetics-special-populations","category-special-populations"],"acf":[],"yoast_head":"\nCardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report - The Premiere Heart Health Education Platform<\/title>\n<meta name=\"description\" content=\"Meet the "Masters Athlete." This is a person over age 50 who feels like they are in the prime of their life. They run long races, bike for hundreds of miles, and spend hours in the pool. To the outside world, they look like the picture of health. They have a slow, steady resting pulse and plenty of energy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curingheartdisease.com\/zh\/50\u5c81\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u5fc3\u623f\u98a4\u52a8\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u7684\u5fc3\u8840\u7ba1\u98ce\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report - The Premiere Heart Health Education Platform\" \/>\n<meta property=\"og:description\" content=\"Meet the "Masters Athlete." This is a person over age 50 who feels like they are in the prime of their life. They run long races, bike for hundreds of miles, and spend hours in the pool. To the outside world, they look like the picture of health. They have a slow, steady resting pulse and plenty of energy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curingheartdisease.com\/zh\/50\u5c81\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u5fc3\u623f\u98a4\u52a8\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u7684\u5fc3\u8840\u7ba1\u98ce\/\" \/>\n<meta property=\"og:site_name\" content=\"The Premiere Heart Health Education Platform\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/curingheartdisease\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-28T14:08:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-02T16:40:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Peter Megdal PhD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:site\" content=\"@RMHDInc\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Peter Megdal PhD\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/\"},\"author\":{\"name\":\"Peter Megdal PhD\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\"},\"headline\":\"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report\",\"datePublished\":\"2025-03-28T14:08:44+00:00\",\"dateModified\":\"2026-08-02T16:40:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/\"},\"wordCount\":2738,\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/post-image-06.jpg\",\"articleSection\":[\"Athletes and Heart Risk\",\"Exercise, Athletes and Aging\",\"Risk, Genetics and Special Populations\",\"Special Populations\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/\",\"name\":\"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report - The Premiere Heart Health Education Platform\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/post-image-06.jpg\",\"datePublished\":\"2025-03-28T14:08:44+00:00\",\"dateModified\":\"2026-08-02T16:40:58+00:00\",\"description\":\"Meet the \\\"Masters Athlete.\\\" This is a person over age 50 who feels like they are in the prime of their life. They run long races, bike for hundreds of miles, and spend hours in the pool. To the outside world, they look like the picture of health. They have a slow, steady resting pulse and plenty of energy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/post-image-06.jpg\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/post-image-06.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"name\":\"The Premiere Heart Health Education Platform\",\"description\":\"To make available to the public the state of the art information on how to reverse heart disease. This is an evidence-based organization utilizing the best available science, including diet, exercise drugs, and other resources to best fight this disease.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curingheartdisease.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\",\"name\":\"Curing Heart Disease, LLC\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"contentUrl\":\"https:\\\/\\\/www.curingheartdisease.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-Curing-Heart-icon-red.png\",\"width\":512,\"height\":512,\"caption\":\"Curing Heart Disease, LLC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/curingheartdisease\",\"https:\\\/\\\/x.com\\\/RMHDInc\",\"https:\\\/\\\/www.instagram.com\\\/rmhdinc\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm8dh9c_D5RfJL7Z1f-yY4w\"],\"description\":\"Curing Heart Disease, LLC is an independent cardiovascular health education organization that publishes evidence-based articles, videos, podcasts, and educational tools about cardiovascular disease prevention, lipid science, nutrition, exercise, and related health topics.\",\"founder\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"foundingPerson\":{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\"},\"knowsAbout\":[\"Cardiovascular health\",\"Cardiovascular disease prevention\",\"Heart disease education\",\"Nutrition\",\"Exercise\",\"Lipid science\",\"Atherosclerosis\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#\\\/schema\\\/person\\\/1468f3f6d05d6929d0583938c1236e53\",\"name\":\"Peter Megdal, PhD\",\"url\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\",\"givenName\":\"Peter\",\"familyName\":\"Megdal\",\"honorificSuffix\":\"PhD\",\"jobTitle\":\"Nutrition Researcher and Cardiovascular Health Educator\",\"description\":\"Peter Megdal, PhD, is a nutrition researcher, cardiovascular health educator, published researcher, and longtime competitive cyclist. He earned a PhD in nutrition from the University of Massachusetts and publishes evidence-based cardiovascular health education through Curing Heart Disease.\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/peters-story\\\/\"},\"worksFor\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"affiliation\":{\"@id\":\"https:\\\/\\\/www.curingheartdisease.com\\\/#organization\"},\"alumniOf\":{\"@type\":\"CollegeOrUniversity\",\"name\":\"University of Massachusetts\"},\"knowsAbout\":[\"Nutrition\",\"Cardiovascular health education\",\"Cardiovascular disease prevention\",\"Lipid science\",\"Exercise physiology\",\"Scientific research\"],\"sameAs\":[\"https:\\\/\\\/www.curingheartdisease.com\\\/author\\\/peter-megdal\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/peter-megdal-56075a2\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u623f\u98a4\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\uff0850\u5c81\u4ee5\u4e0a\uff09\u7684\u5fc3\u8840\u7ba1\u98ce\u9669\u7ba1\u7406\u4e0e\u8bad\u7ec3\u8c03\u6574\uff1a\u4e13\u5bb6\u62a5\u544a\u2014\u2014\u9996\u5c48\u4e00\u6307\u7684\u5fc3\u810f\u5065\u5eb7\u6559\u80b2\u5e73\u53f0","description":"\u8ba4\u8bc6\u4e00\u4e0b\"\u8d44\u6df1\u8fd0\u52a8\u5458\"\u3002\u8fd9\u662f\u4e00\u4f4d\u5e74\u8fc7\u534a\u767e\u3001\u611f\u89c9\u6b63\u5904\u4e8e\u4eba\u751f\u5dc5\u5cf0\u7684\u4eba\u3002\u4ed6\u4eec\u53c2\u52a0\u957f\u8dd1\u6bd4\u8d5b\uff0c\u9a91\u884c\u6570\u767e\u82f1\u91cc\uff0c\u5e76\u5728\u6cf3\u6c60\u91cc\u5ea6\u8fc7\u6570\u5c0f\u65f6\u3002\u5728\u5916\u754c\u770b\u6765\uff0c\u4ed6\u4eec\u582a\u79f0\u5065\u5eb7\u7684\u5316\u8eab\u3002\u4ed6\u4eec\u62e5\u6709\u7f13\u6162\u3001\u5e73\u7a33\u7684\u9759\u606f\u8109\u640f\u548c\u5145\u6c9b\u7684\u7cbe\u529b\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curingheartdisease.com\/zh\/50\u5c81\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u5fc3\u623f\u98a4\u52a8\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u7684\u5fc3\u8840\u7ba1\u98ce\/","og_locale":"zh_CN","og_type":"article","og_title":"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report - The Premiere Heart Health Education Platform","og_description":"Meet the \"Masters Athlete.\" This is a person over age 50 who feels like they are in the prime of their life. They run long races, bike for hundreds of miles, and spend hours in the pool. To the outside world, they look like the picture of health. They have a slow, steady resting pulse and plenty of energy.","og_url":"https:\/\/www.curingheartdisease.com\/zh\/50\u5c81\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u5fc3\u623f\u98a4\u52a8\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\u7684\u5fc3\u8840\u7ba1\u98ce\/","og_site_name":"The Premiere Heart Health Education Platform","article_publisher":"https:\/\/www.facebook.com\/curingheartdisease","article_published_time":"2025-03-28T14:08:44+00:00","article_modified_time":"2026-08-02T16:40:58+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg","type":"image\/jpeg"}],"author":"Peter Megdal PhD","twitter_card":"summary_large_image","twitter_creator":"@RMHDInc","twitter_site":"@RMHDInc","twitter_misc":{"\u4f5c\u8005":"Peter Megdal PhD","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"13 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#article","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/"},"author":{"name":"Peter Megdal PhD","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53"},"headline":"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report","datePublished":"2025-03-28T14:08:44+00:00","dateModified":"2026-08-02T16:40:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/"},"wordCount":2738,"publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg","articleSection":["Athletes and Heart Risk","Exercise, Athletes and Aging","Risk, Genetics and Special Populations","Special Populations"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/","url":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/","name":"\u63a5\u53d7\u8fc7\u6cbb\u7597\u7684\u623f\u98a4\u5927\u5e08\u7ea7\u8fd0\u52a8\u5458\uff0850\u5c81\u4ee5\u4e0a\uff09\u7684\u5fc3\u8840\u7ba1\u98ce\u9669\u7ba1\u7406\u4e0e\u8bad\u7ec3\u8c03\u6574\uff1a\u4e13\u5bb6\u62a5\u544a\u2014\u2014\u9996\u5c48\u4e00\u6307\u7684\u5fc3\u810f\u5065\u5eb7\u6559\u80b2\u5e73\u53f0","isPartOf":{"@id":"https:\/\/www.curingheartdisease.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#primaryimage"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#primaryimage"},"thumbnailUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg","datePublished":"2025-03-28T14:08:44+00:00","dateModified":"2026-08-02T16:40:58+00:00","description":"\u8ba4\u8bc6\u4e00\u4e0b\"\u8d44\u6df1\u8fd0\u52a8\u5458\"\u3002\u8fd9\u662f\u4e00\u4f4d\u5e74\u8fc7\u534a\u767e\u3001\u611f\u89c9\u6b63\u5904\u4e8e\u4eba\u751f\u5dc5\u5cf0\u7684\u4eba\u3002\u4ed6\u4eec\u53c2\u52a0\u957f\u8dd1\u6bd4\u8d5b\uff0c\u9a91\u884c\u6570\u767e\u82f1\u91cc\uff0c\u5e76\u5728\u6cf3\u6c60\u91cc\u5ea6\u8fc7\u6570\u5c0f\u65f6\u3002\u5728\u5916\u754c\u770b\u6765\uff0c\u4ed6\u4eec\u582a\u79f0\u5065\u5eb7\u7684\u5316\u8eab\u3002\u4ed6\u4eec\u62e5\u6709\u7f13\u6162\u3001\u5e73\u7a33\u7684\u9759\u606f\u8109\u640f\u548c\u5145\u6c9b\u7684\u7cbe\u529b\u3002.","breadcrumb":{"@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#primaryimage","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2025\/12\/post-image-06.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.curingheartdisease.com\/cardiovascular-risk-management-and-training-modification-for-the-masters-athlete-50-with-treated-atrial-fibrillation-an-expert-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curingheartdisease.com\/"},{"@type":"ListItem","position":2,"name":"Cardiovascular Risk Management and Training Modification for the Masters Athlete (50+) with Treated Atrial Fibrillation: An Expert Report"}]},{"@type":"WebSite","@id":"https:\/\/www.curingheartdisease.com\/#website","url":"https:\/\/www.curingheartdisease.com\/","name":"\u9996\u9009\u5fc3\u810f\u5065\u5eb7\u6559\u80b2\u5e73\u53f0","description":"\u5411\u516c\u4f17\u63d0\u4f9b\u5173\u4e8e\u5982\u4f55\u9006\u8f6c\u5fc3\u810f\u75c5\u7684\u6700\u65b0\u524d\u6cbf\u4fe1\u606f\u3002\u8fd9\u662f\u4e00\u4e2a\u57fa\u4e8e\u8bc1\u636e\u7684\u7ec4\u7ec7\uff0c\u5229\u7528\u73b0\u6709\u7684\u6700\u4f73\u79d1\u5b66\u6210\u679c\uff0c\u5305\u62ec\u996e\u98df\u3001\u8fd0\u52a8\u3001\u836f\u7269\u548c\u5176\u4ed6\u8d44\u6e90\uff0c\u4ee5\u6700\u597d\u5730\u5bf9\u6297\u8fd9\u79cd\u75be\u75c5\u3002.","publisher":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curingheartdisease.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/www.curingheartdisease.com\/#organization","name":"\u6cbb\u6108\u5fc3\u810f\u75c5\u6709\u9650\u8d23\u4efb\u516c\u53f8","url":"https:\/\/www.curingheartdisease.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","contentUrl":"https:\/\/www.curingheartdisease.com\/wp-content\/uploads\/2026\/06\/cropped-Curing-Heart-icon-red.png","width":512,"height":512,"caption":"Curing Heart Disease, LLC"},"image":{"@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/curingheartdisease","https:\/\/x.com\/RMHDInc","https:\/\/www.instagram.com\/rmhdinc\/","https:\/\/www.youtube.com\/channel\/UCm8dh9c_D5RfJL7Z1f-yY4w"],"description":"\u6cbb\u6108\u5fc3\u810f\u75c5\u6709\u9650\u8d23\u4efb\u516c\u53f8\u662f\u4e00\u5bb6\u72ec\u7acb\u7684 \u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u673a\u6784\uff0c\u81f4\u529b\u4e8e\u53d1\u5e03\u5173\u4e8e\u5fc3\u8840\u7ba1\u75be\u75c5\u9884\u9632\u3001\u8102\u8d28\u79d1\u5b66\u3001\u8425\u517b\u3001\u8fd0\u52a8\u53ca\u76f8\u5173\u5065\u5eb7\u4e3b\u9898\u7684\u5faa\u8bc1\u6587\u7ae0\u3001\u89c6\u9891\u3001\u64ad\u5ba2\u548c\u6559\u80b2\u5de5\u5177\u3002.","founder":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"foundingPerson":{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD"},"knowsAbout":["Cardiovascular health","Cardiovascular disease prevention","Heart disease education","Nutrition","Exercise","Lipid science","Atherosclerosis"]},{"@type":"Person","@id":"https:\/\/www.curingheartdisease.com\/#\/schema\/person\/1468f3f6d05d6929d0583938c1236e53","name":"Peter Megdal, PhD","url":"https:\/\/www.curingheartdisease.com\/peters-story\/","givenName":"Peter","familyName":"Megdal","honorificSuffix":"PhD","jobTitle":"Nutrition Researcher and Cardiovascular Health Educator","description":"Peter Megdal, PhD \u662f\u4e00\u4f4d\u8425\u517b\u5b66\u7814\u7a76\u5458\u3001\u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u8005\u3001\u53d1\u8868\u8fc7\u7814\u7a76\u6210\u679c\u7684\u5b66\u8005\uff0c\u540c\u65f6\u4e5f\u662f\u4e00\u540d\u8d44\u6df1\u7ade\u6280\u81ea\u884c\u8f66\u624b\u3002\u4ed6\u62e5\u6709\u9a6c\u8428\u8bf8\u585e\u5927\u5b66\u8425\u517b\u5b66\u535a\u58eb\u5b66\u4f4d\uff0c\u5e76\u901a\u8fc7\u201cCuring Heart Disease\u201d\u5e73\u53f0\u53d1\u5e03\u57fa\u4e8e\u8bc1\u636e\u7684\u5fc3\u8840\u7ba1\u5065\u5eb7\u6559\u80b2\u5185\u5bb9\u3002.","mainEntityOfPage":{"@id":"https:\/\/www.curingheartdisease.com\/peters-story\/"},"worksFor":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"affiliation":{"@id":"https:\/\/www.curingheartdisease.com\/#organization"},"alumniOf":{"@type":"CollegeOrUniversity","name":"University of Massachusetts"},"knowsAbout":["Nutrition","Cardiovascular health education","Cardiovascular disease prevention","Lipid science","Exercise physiology","Scientific research"],"sameAs":["https:\/\/www.curingheartdisease.com\/author\/peter-megdal\/","https:\/\/www.linkedin.com\/in\/peter-megdal-56075a2\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/posts\/8301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/comments?post=8301"}],"version-history":[{"count":20,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/posts\/8301\/revisions"}],"predecessor-version":[{"id":12298,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/posts\/8301\/revisions\/12298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/media\/8302"}],"wp:attachment":[{"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/media?parent=8301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/categories?post=8301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curingheartdisease.com\/zh\/wp-json\/wp\/v2\/tags?post=8301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}